Global executive with 25 years of U.S. leadership experience across the Texas, New York and Nordic life science and medtech ecosystems, driving healthcare innovation and building impactful public–private partnerships across industry, government, and academia — including with the Texas Medical Center (TMC) and the Ministry of Foreign Affairs of Denmark.

Christina is CEO and Founder of Convergence, an advisory practice based in Copenhagen and New York that helps scientists, organizations, and companies identify strategic partners, structure collaborations, and build international programs that translate research into real-world healthcare impact.

Serving as Program Director, Strategic & Fractional Advisor, Board Member and Board Advisory Member to life science organizations, she drives value positioning, market access, and stakeholder engagement, leveraging a deep Nordic–U.S. network of government and academic decision-makers, clinicians, researchers, patient advocates, and innovators. Christina is Co-founder of TMC | Denmark BioBridge – a bilateral partnership between Texas and Denmark. Partner at CVX Ventures – a Copenhagen-based venture capital network connecting investors with early-stage Nordic companies. Fractional Advisor at Femtech Studios, a Nordic venture builder.

Focus Areas: Women’s Health, Brain Health, Gut Microbiome, Healthcare Resilience, Value-Based &Accountable Care Innovation.